Med. praxi. 2025;22(3):223-224 | DOI: 10.36290/med.2025.049

The most common mistakes in the diagnosis of idiopathic intestinal inflammation

MUDr. Aleš Novotný
4. interní klinika VFN a 1. LF UK, Praha

The incidence of idiopathic bowel disease (IBD) is increasing. IBDs are a high patient burden and are becoming a significant socioeconomic problem. Correct and early diagnosis is crucial for adequate treatment, which in the best case should prevent or at least minimize the risk of structural changes in the digestive tract, thus improving the outlook of patients with IBD.

Keywords: Crohn's disease, ulcerative colitis, fecal calprotectin, immunosuppression, superinfection.

Received: April 11, 2025; Revised: May 28, 2025; Accepted: June 3, 2025; Published: June 26, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Novotný A. The most common mistakes in the diagnosis of idiopathic intestinal inflammation. Med. praxi. 2025;22(3):223-224. doi: 10.36290/med.2025.049.
Download citation

References

  1. . Abdalla MI, Sandler RS, Kappelman MD, et al. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners. Inflamm Bowel Dis. 2017 Feb;23(2):325-331. Go to original source... Go to PubMed...
  2. . Barbara G, Cremon C. Inflammatory bowel disease and irritable bowel syndrome: similarities and differences. Curr Opin Gastroenterol. 2014 Jul;30(4):352-8. Go to original source... Go to PubMed...
  3. . Campbell JP, Zierold C, Rode AM et al. Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Iritable Bowel Syndrome. J Clin Gastroenterol 2021 Mar 1;55(3):239-243. Go to original source... Go to PubMed...
  4. . Louis E. When it is not inflammatory bowel disease: differential diagnosis. Curr Opin Gastroenterol. 2015 Jul;31(4):283-9. Go to original source... Go to PubMed...
  5. . Mináriková P. Diagnostika idiopatických střevních zánětů. Medicína po promoci. 2021;3.




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.